Evogene (EVGN) Reports Q3 Loss of $0.16/Share

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.16), versus ($0.19) reported last year. Revenue for the quarter came in at $97 thousand, versus $367 thousand reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating